SRPT vs VCTR · rev $1.90B vs P/E 14, rev $893.5M
Sarepta Therapeutics Inc (SRPT) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
SRPT currently screens at market cap $2.34B. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the SRPT and VCTR stock pages for the full models.
Not investment advice.